What results from Wegovy can you realistically expect?

What the trial numbers mean for you specifically

Fifteen percent sounds precise, but averages flatten a wide spread. In STEP 1, some participants lost considerably more; others lost less. The trial enrolled adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition, and excluded people with type 2 diabetes — so the evidence applies most directly to that group. If your circumstances differ, so might your trajectory.

Three things reliably shift results in the data: the dose reached, the duration of treatment, and what happens alongside the injection. Participants who reached and maintained the 2.4mg dose for the full trial period tended to see the largest reductions. Reduced-calorie eating and increased physical activity were part of the protocol in every STEP trial arm, the medicine worked alongside those changes, not instead of them. A question our prescribers hear regularly is whether the lifestyle piece really matters once appetite is suppressed. The trial answer is yes: the placebo group, who also received lifestyle support, lost around 2.4% on average. The gap between 2.4% and 15% is the medicine's contribution; the lifestyle support is baked into both arms.

The wider Wegovy results picture includes data beyond STEP 1 (cardiovascular outcomes, maintenance after stopping, and the newer 7.2mg dose) and is worth reading if you want the full context before deciding.

How the titration schedule shapes what you notice early on

Semaglutide treatment begins at 0.25mg and increases in steps roughly every four weeks, guided by your prescriber, up to the 2.4mg maintenance dose. The earlier stages are primarily about letting your body adjust; significant appetite change and weight loss typically build as the dose increases. If you are keeping the pen in the fridge door and wondering after week three why things feel slow, that is normal, the starter doses are doing a different job than the maintenance dose does.

This means that how long it takes to see results from Wegovy is inseparable from where you are in the titration sequence. Most people notice meaningful appetite change somewhere between the 0.5mg and 1.0mg stages, though the timing varies. If you want a closer look at how long before you see results from Wegovy, that page breaks down what to expect at each stage of the titration sequence. Measurable weight loss tends to be modest in the first month and more pronounced from month three onward, and for a detailed week-by-week picture of how long it takes to see results from Wegovy, that guide is worth reading before your first injection arrives. Patience through the titration period is genuinely part of the treatment, not a sign that it is not working.

The MHRA's approval of the 7.2mg single-dose pen in April 2026 extended the ceiling for people who have already reached 2.4mg and want to go further. That dose is for adults with a BMI of 30 or above; whether it is appropriate is a clinical judgement made with your prescriber, not a straightforward upgrade to request.

When results plateau or feel disappointing

A plateau after six months is common enough that NICE has built a review point into its guidance. Under NICE's appraisal of semaglutide for weight management (TA875), clinicians are advised to consider stopping treatment if a patient has not lost at least 5% of their body weight after six months on the maintenance dose. That threshold is a clinical signal, not a ceiling (many people lose considerably more) but it is a useful prompt to review what is happening.

Common reasons for a plateau include not yet reaching the highest tolerated dose, changes in diet that partly offset appetite suppression, or simply the natural slowing that happens as the body adapts. A slower-than-expected response is worth discussing with your prescriber rather than adjusting anything independently. The right next step (continuing, titrating further, or reviewing lifestyle factors) depends on the full picture, not just the number on the scales. For a sense of how the cost of treatment fits into that longer-term picture, the guide to Wegovy pricing in the UK explains what private treatment typically includes beyond the medicine itself.

The decision this page is really helping you make

Most people searching for results from Wegovy are weighing a real question: is this worth trying for someone in my situation? The honest answer is that the clinical evidence is stronger than for most weight-management medicines, and the results for many people are clinically meaningful. But Wegovy is a prescription-only medicine, and the right starting point is a clinical assessment, not a statistical average.

At nume, every consultation is read by a GPhC-registered independent prescriber on the same day. There are no waiting lists and no referral needed. If you want to explore the full range of weight-loss treatment options before deciding, or read more about how Wegovy works as a treatment, both pages give you the background to have a well-informed conversation with a prescriber. When you are ready, start your free consultation and a prescriber will assess whether semaglutide is clinically suitable for you.